| Literature DB >> 31903043 |
Kazım Cihan Can1, Demet Karnak2, Halise devrİmcİ Özgüven1.
Abstract
Clozapine is the gold-standard antipsychotic agent for treatment-resistant schizophrenia. Yet with all its clinical efficacy, there are numerous adverse effects associated with clozapine. Although many, such as leucopenia and agranulocytosis, are well established, there is little published material on the drug's rare adverse effects. Among these, very little is known about clozapine-induced interstitial lung disease. Here we present such a case. We focus on its clinical aspects and discuss its relationship to the extant literature. Copyright:Entities:
Keywords: Clozapine; interstitial lung disease; schizophrenia
Year: 2019 PMID: 31903043 PMCID: PMC6927085 DOI: 10.29399/npa.23406
Source DB: PubMed Journal: Noro Psikiyatr Ars ISSN: 1300-0667 Impact factor: 1.339